These 3 Aussie stocks could skyrocket and stay there for decades

Let's see what sets these stocks apart from the rest.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • CSL Ltd, a biotechnology leader with a robust plasma collection network and extensive R&D investment, offers high barriers to entry and future growth prospects despite recent share price pressure.
  • Pro Medicus, known for its Visage medical imaging platform, enjoys high margins and growth potential with sticky recurring revenues from long-term U.S. contracts, positioned to benefit from global healthcare digitization.
  • WiseTech Global, with its indispensable CargoWise platform in logistics, maintains a dominant market position with high switching costs and is poised for long-term growth through global trade expansion and strategic acquisitions.

Every now and then, the ASX delivers stocks with the potential not only to climb higher but to keep delivering for shareholders long after the initial run-up.

These are the kinds of businesses with strong competitive advantages, huge global markets, and management teams that know how to execute.

Let's now look at three Aussie stocks that tick these boxes and could be destined to skyrocket — and stay there for decades.

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.

Image source: Getty Images

CSL Ltd (ASX: CSL)

CSL is a biotechnology giant that has turned into one of Australia's greatest corporate success stories. With its plasma therapies, vaccines, and specialty treatments, this Aussie stock has built a global footprint that few rivals can match.

What makes CSL so attractive for long-term investors is its moat. The company operates one of the world's largest plasma collection networks and reinvests heavily into research and development each year. This combination creates high barriers to entry and a pipeline of new treatments to fuel future growth.

While its share price has been under pressure recently, history suggests that CSL has the resilience and the innovation to keep compounding earnings well into the future.

Pro Medicus Ltd (ASX: PME)

Another Aussie stock to look at is Pro Medicus. It is a medical imaging software provider that's taking the healthcare world by storm. Its Visage platform allows hospitals and radiologists to view, share, and analyse images faster and more efficiently than traditional systems.

Once installed, Visage generates sticky recurring revenues from long-term contracts, particularly in the U.S. healthcare system. With major hospitals already on board and new deals being signed, Pro Medicus has plenty of room to grow.

Its margins are among the best on the ASX, and with the digitisation of healthcare accelerating globally, Pro Medicus could remain a top performer for decades.

WiseTech Global Ltd (ASX: WTC)

Finally, WiseTech Global has become an indispensable player in the logistics industry. The Aussie stock's CargoWise platform is used worldwide by freight forwarders, customs brokers, and transport companies to manage supply chains.

The company has carved out a dominant position by offering a single, integrated solution that replaces clunky, outdated systems. Its customer base is sticky, with high switching costs that make it difficult for rivals to compete.

With global trade volumes expected to keep rising and WiseTech expanding its product suite with acquisitions, its long-term growth potential is enormous. For investors, it could be a classic example of an ASX tech company with global scalability.

Motley Fool contributor James Mickleboro has positions in CSL, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Growth Shares

2 rapidly growing ASX shares down over 50% to buy now

These two ASX shares are down heavily, potentially creating a compelling buying opportunity.

Read more »

A boy is about to rocket from a copper-coloured field of hay into the sky.
Growth Shares

A rare buying opportunity in 1 of Australia's top shares?

I think this business is a significant opportunity.

Read more »

Happy office workers stand together.
Growth Shares

2 ASX 200 shares that could dominate the next decade

These shares are market-leaders and could be well-positioned for growth over the long term.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Growth Shares

I'd buy these ASX 200 shares if I wanted to invest for the next 20 years

The best long-term shares are often tied to needs that should keep expanding. I think these ASX 200 shares fit…

Read more »

A group of businesspeople clapping.
Growth Shares

Why I think this could be one of the best ASX 200 growth shares to buy

This company is already winning advisers, attracting flows, and taking share in a market that still has room for better…

Read more »

Man on a tablet in a room with data centre technology.
Growth Shares

Is NextDC the hottest ASX growth stock right now?

High valuation and yet to reach profitability, but is this ASX growth stock a buy?

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Growth Shares

This ASX tech stock could be one of the most overlooked AI infrastructure plays on the market

This stock sits at the centre of Australia's AI infrastructure boom.

Read more »

A white and black clock face is shown with Time to Buy written.
Growth Shares

2 of the best ASX 200 shares to buy and hold for 10 years

These shares could be top picks for investors wanting to build wealth over the long term.

Read more »